SaMD based cardiovascular diagnostic device (ppg and ecg wearables)
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- CDRH Acquisition Liaison cdrhacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is seeking an external contractor to develop benchmark reference datasets for validating and supporting algorithm development of Software as a Medical Device (SaMD) based cardiovascular diagnostic devices, specifically photoplethysmography (PPG) and electrocardiogram (ECG) wearables. This is a new requirement with no set-aside restriction, and the solicitation is forecasted to release on February 1, 2026, with an estimated award date of April 1, 2026.
The estimated award value ranges from $25,000 to $250,000, and the contract falls under NAICS code 541714 (Research and Development in Biotechnology). Interested contractors should contact the FDA's Center for Devices and Radiological Health (CDRH) Acquisitions team at cdrhacquisitions@fda.hhs.gov for additional information and to express interest in this opportunity.
Forecast text
We will use external contractor to work with us and develop benchmark reference datasets for validating (and algorithm development) for SaMD based cardiovascular diagnostic device (ppg and ecg wearables)
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast